UK-India Making Tomorrow’s Medicines Together
The UK Life Sciences sector has over 5,600 companies generating £60 billion worth of revenue to the country’s economy
The UK Department for International Trade (DIT) India led by a large delegation of 65 people from 30 innovative UK companies at the Vibrant Gujarat Summit, 2017 showcased the capability in the Life Sciences sector with a particular focus on pharmaceutical manufacturing and development. UK Life Sciences companies have participated in the trade mission with the aim of forging new partnerships.
Dominic Asquith KCMG, British High Commissioner to India, said, “It is remarkable that a large percentage of medicines prescribed in the UK are ‘Made in India’ and a demonstration of how our two countries are so successfully working together in the Healthcare and Life Science sectors. These medicines make an important contribution to controlling the costs of healthcare provided through our National Health Service. We have chosen to focus our country session at Vibrant Gujarat on life sciences and, in particular, the area of pharmaceutical manufacture and development. This is because we believe the UK is a natural partner to India in this sector and that we can do much more together.
The UK is a recognised global leader in medical research, with a proven track record of innovation, cutting-edge technology and commercialisation, on all of which it can collaborate with India who is a global leader in generic drug manufacturing.”
The UK has one of the world’s leading Life Science sectors. Over the past 60 years there has been a revolution in the number, specificity and safety of human medicines with the UK playing an important role in this process. The UK Life Sciences sector has over 5,600 companies generating £60 billion worth of revenue to the country’s economy.
Top themes and market attention on: